Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

Cost‐effectiveness of left ventricular assist devices as destination therapy in the United Kingdom

Abstract Aims Continuous‐flow left ventricular assist devices (LVADs) as destination therapy (DT) are a recommended treatment by National Institute for Health and Care Excellence England for end‐stage heart failure patients ineligible for cardiac transplantation. Despite the fact that DT is frequent...

Full description

Bibliographic Details
Main Authors: Stephan Schueler, Scott C. Silvestry, William G. Cotts, Mark S. Slaughter, Wayne C. Levy, Richard K. Cheng, Jennifer A. Beckman, Jonas Villinger, Eleni Ismyrloglou, Stelios I. Tsintzos, Claudius Mahr
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Mechanical circulatory support
Ventricular assist device
Destination therapy
Cost‐effectiveness
Online Access:https://doi.org/10.1002/ehf2.13401

Internet

https://doi.org/10.1002/ehf2.13401

Similar Items